Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS - MarketWatch (press release)
Posted by admin / Under Growth Hormone Releasing HormoneTheratechnologies Announces Publication of Second Phase 3 Results in JAIDS MarketWatch (press release) Its most advanced compound, tesamorelin, is an analogue of the human growth hormone releasing factor. In 2009, Theratechnologies submitted a New Drug ... |
Published on Saturday 13th of March 2010 10:13:11 AM
Read more...
Theratechnologies Says Tesamorelin Review Set For May 27 - Wall Street Journal
Posted by admin / Under Growth Hormone Releasing HormoneTheratechnologies Says Tesamorelin Review Set For May 27 Wall Street Journal Theratechnologies submitted an NDA in May 2009 for tesamorelin, an analogue of the human growth hormone releasing factor proposed for the treatment of ... |
Published on Saturday 13th of March 2010 10:13:11 AM
Read more...
Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R ... - PR Newswire (press release)
Posted by admin / Under Growth Hormone Releasing HormoneAbbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R ... PR Newswire (press release) LupronĀ® Depot belongs to a class of medications known as gonadotropin releasing hormone agonists (GnRHa). Lupron was first approved for subcutaneous ... |
Published on Saturday 13th of March 2010 10:13:11 AM
Read more...
FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month ... - PR Newswire (press release)
Posted by admin / Under Growth Hormone Releasing HormoneFDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month ... PR Newswire (press release) TRELSTARĀ® 22.5 mg releases triptorelin pamoate, a gonadotropin releasing hormone (GnRH) agonist, over a prolonged period and, in turn, ... |
Published on Saturday 13th of March 2010 10:13:11 AM
Read more...
US FDA advisory meetings through March 25 - London South East
Posted by admin / Under Growth Hormone Releasing Hormone
Published on Saturday 13th of March 2010 10:13:11 AM
Read more...



